Shell Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Shell Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,216	Closed	-$485K	–	1397
2021 Q4	$485K	Buy	5,216 +25	+0.5%	+$1.65K	0.01%	913
2021 Q3	$309K	Buy	+5,191	New	+$307K	0.01%	1074
2021 Q1	–	Sell	-7,884	Closed	-$606K	–	1509
2020 Q4	$606K	Hold	7,884	–	–	0.01%	712
2020 Q3	$590K	Hold	7,884	–	–	0.01%	603
2020 Q2	$496K	Sell	7,884 -65	-0.8%	-$3.58K	0.01%	661
2020 Q1	$334K	Sell	7,949 -120	-1%	-$5.5K	0.01%	834
2019 Q4	$366K	Sell	8,069 -157	-2%	-$7.42K	0.01%	994
2019 Q3	$377K	Sell	8,226 -70	-0.8%	-$3.94K	0.01%	1000
2019 Q2	$486K	Sell	8,296 -189	-2%	-$9.77K	0.01%	934
2019 Q1	$380K	Hold	8,485	–	–	0.01%	1004
2018 Q4	$330K	Sell	8,485 -700	-8%	-$27.5K	0.01%	967
2018 Q3	$423K	Buy	+9,185	New	+$372K	0.01%	1008

Shell Asset Management's ARNA Position: Q1 2022 in Review

Shell Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,216 shares — an estimated $485K sold.

Shell Asset Management first reported a position in ARNA in Q3 2018 and held it in 12 quarters. The position peaked at $606K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Shell Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Shell Asset Management sold 5,216 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $485K.
Shell Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 12 quarters.
Shell Asset Management's Arena Pharmaceuticals Inc position peaked at $606K in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Shell Asset Management's 13F filing for Q1 2022, filed 4 May 2022.